3 news items
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
TAK
26 Apr 24
outcomes and limited treatment options. Some patients with metastatic CRC may benefit from personalized therapeutic strategies based on molecular
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
TAK
22 Apr 24
)In this press release, statements made with respect to current plans, estimates, strategies and beliefs and other
Championing Rare Voices on Rare Disease Day
TAK
26 Feb 24
over three years in support of the first-ever National Strategy for Drugs for Rare Diseases, with funding made available to provinces and territories
- Prev
- 1
- Next